Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia

PURPOSE: The aim of the current study was to determine whether the degree of mutation clearance at remission predicts the risk of relapse in patients with acute myeloid leukemia (AML). PATIENTS AND METHODS: One hundred thirty-one previously untreated patients with AML who received intensive inductio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Morita, Kiyomi, Kantarjian, Hagop M., Wang, Feng, Yan, Yuanqing, Bueso-Ramos, Carlos, Sasaki, Koji, Issa, Ghayas C., Wang, Sa, Jorgensen, Jeffrey, Song, Xingzhi, Zhang, Jianhua, Tippen, Samantha, Thornton, Rebecca, Coyle, Marcus, Little, Latasha, Gumbs, Curtis, Pemmaraju, Naveen, Daver, Naval, DiNardo, Courtney D., Konopleva, Marina, Andreeff, Michael, Ravandi, Farhad, Cortes, Jorge E., Kadia, Tapan, Jabbour, Elias, Garcia-Manero, Guillermo, Patel, Keyur P., Futreal, P. Andrew, Takahashi, Koichi
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2018
Assuntos:
RAPID COMMUNICATION
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6008108/
https://ncbi.nlm.nih.gov/pubmed/29702001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.77.6757
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados